Maalox



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Vitamin Supplementation 23.7%
Flatulence 13.2%
Gastrooesophageal Reflux Disease 10.5%
Dyspepsia 7.9%
Diarrhoea 5.3%
Gastric Disorder 5.3%
Gastritis 5.3%
Ulcer 5.3%
Abdominal Pain Upper 2.6%
Anticoagulant Therapy 2.6%
Arthritis 2.6%
Blood Cholesterol Increased 2.6%
Gallbladder Disorder 2.6%
Hot Flush 2.6%
Hyperchlorhydria 2.6%
Hypertension 2.6%
Thyroid Disorder 2.6%
Therapeutic Response Unexpected 23.5%
Off Label Use 17.6%
Amnesia 5.9%
Death 5.9%
Depression 5.9%
Medication Error 5.9%
Pleurisy 5.9%
Product Packaging Issue 5.9%
Pulmonary Oedema 5.9%
Sleep Apnoea Syndrome 5.9%
Underdose 5.9%
Wrong Technique In Drug Usage Process 5.9%
Secondary
Product Used For Unknown Indication 23.2%
Dyspepsia 11.9%
Gastrooesophageal Reflux Disease 10.8%
Pain 9.2%
Drug Use For Unknown Indication 8.6%
Flatulence 4.3%
Wolff-parkinson-white Syndrome 3.8%
Abdominal Pain Upper 3.2%
Duodenal Ulcer 2.7%
Hypertension 2.7%
Anxiety 2.2%
Asthma 2.2%
Constipation 2.2%
Diabetes Mellitus 2.2%
Drug Dependence 2.2%
Ulcer 2.2%
Convulsion 1.6%
Depression 1.6%
Diverticulitis 1.6%
Infection Prophylaxis 1.6%
Faeces Discoloured 9.3%
Oedema Peripheral 9.3%
Weight Decreased 9.3%
White Blood Cell Count Increased 9.3%
Nausea 7.0%
Pancreatitis Acute 7.0%
Scleral Discolouration 7.0%
Nephrolithiasis 4.7%
Product Quality Issue 4.7%
Therapeutic Response Unexpected 4.7%
Underweight 4.7%
Vomiting 4.7%
Abdominal Discomfort 2.3%
Constipation 2.3%
Cytolytic Hepatitis 2.3%
Death 2.3%
Diarrhoea 2.3%
Drug Ineffective 2.3%
Gastric Disorder 2.3%
Gastrooesophageal Reflux Disease 2.3%
Concomitant
Drug Use For Unknown Indication 30.9%
Product Used For Unknown Indication 13.6%
Pain 8.0%
Gastrooesophageal Reflux Disease 5.3%
Hypertension 4.7%
Prophylaxis 4.5%
Depression 4.2%
Dyspepsia 3.5%
Constipation 3.3%
Nausea 2.9%
Rheumatoid Arthritis 2.8%
Insomnia 2.6%
Anxiety 2.3%
Arthritis 1.8%
Headache 1.8%
Non-small Cell Lung Cancer 1.7%
Back Pain 1.6%
Gastric Ulcer 1.6%
Renal Transplant 1.6%
Diabetes Mellitus 1.5%
Vomiting 11.4%
Weight Decreased 10.0%
Urinary Tract Infection 9.0%
Pancreatitis Acute 6.9%
Pneumonia 5.9%
Weight Increased 5.2%
Thrombocytopenia 4.8%
Withdrawal Syndrome 4.5%
Pain 4.2%
White Blood Cell Count Decreased 4.2%
Interstitial Lung Disease 3.8%
Rhabdomyolysis 3.8%
Rash 3.5%
Tremor 3.5%
Tumour Lysis Syndrome 3.5%
Wound Infection 3.5%
Death 3.1%
Off Label Use 3.1%
Renal Failure Acute 3.1%
Walking Aid User 3.1%
Interacting
Abdominal Discomfort 100.0%
Blood Potassium Increased 25.0%
Faeces Discoloured 25.0%
Lipase Increased 25.0%
Presyncope 25.0%